Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Arrowhead Pharmaceuticals (ARWR) Cash from Discontinued Operations: 2010-2014

Historic Cash from Discontinued Operations for Arrowhead Pharmaceuticals (ARWR) over the last 3 years, with Mar 2014 value amounting to -$46.9 million.

  • Arrowhead Pharmaceuticals' Cash from Discontinued Operations changed negligibly% to -$46.9 million in Q1 2014 from the same period last year, while for Mar 2014 it was -$187.6 million, marking a year-over-year decrease of 33.33%. This contributed to the annual value of -$354 for FY2013, which is 26.43% down from last year.
  • According to the latest figures from Q1 2014, Arrowhead Pharmaceuticals' Cash from Discontinued Operations is -$46.9 million, which was down 0.00% from -$46.9 million recorded in Q4 2013.
  • Arrowhead Pharmaceuticals' 5-year Cash from Discontinued Operations high stood at $2.9 million for Q1 2011, and its period low was -$46.9 million during Q1 2012.
  • Over the past 3 years, Arrowhead Pharmaceuticals' median Cash from Discontinued Operations value was -$46.9 million (recorded in 2014), while the average stood at -$41.7 million.
  • In the last 5 years, Arrowhead Pharmaceuticals' Cash from Discontinued Operations skyrocketed by 99.94% in 2011 and then slumped by 260,502,766.67% in 2013.
  • Over the past 5 years, Arrowhead Pharmaceuticals' Cash from Discontinued Operations (Quarterly) stood at -$544,335 in 2010, then soared by 99.92% to -$420 in 2011, then skyrocketed by 95.71% to -$18 in 2012, then tumbled by 260,502,766.67% to -$46.9 million in 2013, then remained steady at -$46.9 million in 2014.
  • Its Cash from Discontinued Operations stands at -$46.9 million for Q1 2014, versus -$46.9 million for Q4 2013 and -$46.9 million for Q3 2013.